Cheng Cheng-Ming, Hong Hong-Jye, Liu Ju-Chi, Shih Neng-Lang, Juan Shu-Hui, Loh Shih-Hurng, Chan Paul, Chen Jin-Jer, Cheng Tzu-Hurng
Department of Obstetrics and Gynecology, Changhua Christian Hospital, Changhua, Taiwan, ROC.
Mol Pharmacol. 2003 May;63(5):1002-11. doi: 10.1124/mol.63.5.1002.
Endothelin-1 (ET-1) has been implicated in fibroblast proliferation. However, the mechanism involving ET-1 is not clear. The present study was performed to examine the role of endogenous ET-1 in ET-1-stimulated fibroblast proliferation and to investigate the regulatory mechanism of ET-1-induced ET-1 gene expression in cardiac fibroblasts. Both ET(A) receptor antagonist [(hexahydro-1H-azepinyl)carbonyl-Leu-D-Trp-D-OH (BQ485)] and endothelin-converting enzyme inhibitor (phosphoramidon) inhibited the increased DNA synthesis caused by ET-1. ET-1 gene was induced by ET-1, as revealed with Northern blotting and ET-1 promoter activity assay. ET-1 increased intracellular reactive oxygen species (ROS), which were significantly inhibited by BQ485 and antioxidants. Antioxidants suppressed ET-1 gene expression and DNA synthesis stimulated by ET-1. ET-1 activated mitogen-activated protein kinases (MAPK), including extracellular signal-regulated kinase (ERK), p38 MAPK, and c-Jun N-terminal kinase, which were significantly inhibited by antioxidants. Only ERK inhibitor U0126 could inhibit ET-1-induced transcription of the ET-1 gene. Cotransfection of dominant-negative mutant of Ras, Raf, and MEK1 decreased the ET-1-induced increase in ET-1 transcription, suggesting that the Ras-Raf-ERK pathway is required for ET-1 action. Truncation and mutational analysis of the ET-1 gene promoter showed that the activator protein-1 (AP-1) binding site was an important cis-element in ET-1-induced ET-1 gene expression. Antioxidants attenuated the ET-1-stimulated AP-1 binding activity. Our data suggest that ROS were involved in ET-1-induced fibroblast proliferation and mediated ET-1-induced activation of ERK pathways, which culminated in ET-1 gene expression.
内皮素-1(ET-1)与成纤维细胞增殖有关。然而,涉及ET-1的机制尚不清楚。本研究旨在探讨内源性ET-1在ET-1刺激的成纤维细胞增殖中的作用,并研究ET-1诱导心脏成纤维细胞中ET-1基因表达的调控机制。ET(A)受体拮抗剂[(六氢-1H-氮杂环庚烷基)羰基-Leu-D-Trp-D-OH(BQ485)]和内皮素转换酶抑制剂(磷酰胺素)均抑制了ET-1引起的DNA合成增加。Northern印迹和ET-1启动子活性测定显示,ET-1可诱导ET-1基因。ET-1增加细胞内活性氧(ROS),而BQ485和抗氧化剂可显著抑制其增加。抗氧化剂抑制ET-1基因表达以及ET-1刺激的DNA合成。ET-1激活丝裂原活化蛋白激酶(MAPK),包括细胞外信号调节激酶(ERK)、p38 MAPK和c-Jun N末端激酶,而抗氧化剂可显著抑制这些激酶的活性。只有ERK抑制剂U0126能够抑制ET-1诱导的ET-1基因转录。Ras、Raf和MEK1的显性负突变体共转染可降低ET-1诱导的ET-1转录增加,表明Ras-Raf-ERK途径是ET-1发挥作用所必需的。ET-1基因启动子的截短和突变分析表明,激活蛋白-1(AP-1)结合位点是ET-1诱导ET-1基因表达中的一个重要顺式元件。抗氧化剂减弱了ET-1刺激的AP-1结合活性。我们的数据表明,ROS参与了ET-1诱导的成纤维细胞增殖,并介导了ET-1诱导的ERK途径激活,最终导致ET-1基因表达。